Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia

Hypertension

Volumn 61, Issue 3, 2013, Pages 655-661

  Kvehaugen, Anne Stine ^a   Melien, Øyvind ^a   Holmen, Oddgeir Lingaas ^b   Laivuori, Hannele ^c   Øian, Pål ^d   Andersgaard, Alice Beathe ^e   Dechend, Ralf ^f   Staff, Anne Cathrine ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF TROMSØ   (Norway)

^e South Eastern Norway Regional Health Authority   (Norway)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

angiotensin II; G proteins; hypertension; polymorphism; preeclampsia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; RGS2 PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BLOOD VESSEL BIOPSY; COHORT ANALYSIS; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE COURSE; ECLAMPSIA; FEMALE; GENETIC CODE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NORWAY; PHENOTYPE; POPULATION RESEARCH; PREECLAMPSIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL SPECIMEN BANKS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; NORWAY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; RECEPTOR, ANGIOTENSIN, TYPE 1; RGS PROTEINS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84874356849     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00331     Document Type: Article

References (34)

1. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;77:67-75.
2. Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med. Sci. 2007;334:291-295.
3. Neves SR, Ram PT, Iyengar R. G protein pathways. Science. 2002;296:1636-1639.
4. Bastin G, Heximer SP. Intracellular regulation of heterotrimeric G-protein signaling modulates vascular smooth muscle cell contraction. Arch Biochem Biophys. 2011;510:182-189.
5. Melien O. Heterotrimeric G proteins and disease. Methods Mol Biol. 2007;361:119-144.
6. Siffert W. G-protein beta3 subunit 825T allele and hypertension. Curr Hypertens Rep. 2003;5:47-53.
7. Klenke S, Kussmann M, Siffert W. The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics. 2011;21:594-606.
8. He G, Liu X, Fan P, Liu R, Huang Y, Wang X, Li Q, Wu H, Liu Y, Liu B, Bai H. The C825T polymorphism in the G-protein beta 3 subunit gene in Chinese patients with preeclampsia. Hypertens Pregnancy. 2009;28:156-167.
9. Jansen MW, Bertina RM, Vos HL, Bloemenkamp KW, Helmerhorst FM, Wladimiroff JW, de Groot CJ. C825T polymorphism in the human G protein beta 3 subunit gene and preeclampsia; a case control study. Hypertens Pregnancy. 2004;23:211-218.
10. Tang X, Guruju M, Rajendran GP, Isler CM, Martin JN Jr, Kumar A. Role of C825T polymorphism of GNbeta3 gene in preeclampsia. Hypertens Pregnancy. 2006;25:93-101.
11. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689.
12. Li Y, Hashim S, Anand-Srivastava MB. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells. Cardiovasc Res. 2005;66:503-511.
13. Kobashi G, Hata A, Ohta K, Yamada H, Kato EH, Minakami H, Fujimoto S, Kondo K. A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J Hum Genet. 2004;49:182-186.
14. Palatini P, Ceolotto G, Dorigatti F, Mos L, Santonastaso M, Bratti P, Papparella I, Pessina AC, Semplicini A. Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am J Hypertens. 2009;22:208-214.
15. Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med. 2008;10:560-574.
16. Zhao L, Dewan AT, Bracken MB. Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2012;25:2676-2680.
17. Lee HK, Park DW, Bae JH, Kim HJ, Shin DG, Park JS, Lee JG, Lee SJ, Bae YS, Baek SH. RGS2 is a negative regulator of STAT3-mediated Nox1 expression. Cell Signal. 2012;24:803-809.
18. Tsang S, Woo AY, Zhu W, Xiao RP. Deregulation of RGS2 in cardiovascular diseases. Front Biosci (Schol Ed). 2010;2:547-557.
19. Rosskopf D, Schürks M, Rimmbach C, Schäfers R. Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol. 2007;374:429-469.
20. Semplicini A, Lenzini L, Sartori M, Papparella I, Calò LA, Pagnin E, Strapazzon G, Benna C, Costa R, Avogaro A, Ceolotto G, Pessina AC. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens. 2006;24:1115-1124.
21. Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension. 2010;56:1026-1034.
22. Harsem NK, Roald B, Braekke K, Staff AC. Acute atherosis in decidual tissue: not associated with systemic oxidative stress in preeclampsia. Placenta. 2007;28:958-964.
23. Andersgaard AB, Herbst A, Johansen M, Ivarsson A, Ingemarsson I, Langhoff-Roos J, Henriksen T, Straume B, Oian P. Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol Scand. 2006;85:929-936.
24. Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169:505-514.
25. Sun X, Kaltenbronn KM, Steinberg TH, Blumer KJ. RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol Pharmacol. 2005;67:631-639.
26. Melien O, Thoresen GH, Sandnes D, Ostby E, Christoffersen T. Activation of p42/p44 mitogen-activated protein kinase by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2alpha in hepatocytes is sustained, and like the effect of epidermal growth factor, mediated through pertussis toxin-sensitive mechanisms. J Cell Physiol. 1998;175: 348-358.
27. Osei-Owusu P, Sabharwal R, Kaltenbronn KM, Rhee MH, Chapleau MW, Dietrich HH, Blumer KJ. Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling. J Biol Chem. 2012;287:12541-12549.
28. Herse F, Staff AC, Hering L, Müller DN, Luft FC, Dechend R. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and preeclampsia. J Mol Med. 2008;86:697-703.
29. Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010;55:1239-1245.
30. Hladunewich MA, Kingdom J, Odutayo A, Burns K, Lai V, O'Brien T, Gandhi S, Zimpelmann J, Kiss A, Miller J, Cherney D. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab. 2011;96:3517-3524.
31. AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 2001;7:1003-1009.
32. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE, Broughton Pipkin F, Read RJ. A redox switch in angiotensinogen modulates angiotensin release. Nature. 2010;468:108-111.
33. Lee HK, Yeo S, Kim JS, Lee JG, Bae YS, Lee C, Baek SH. Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2. Mol Pharmacol. 2010;78:478-485.
34. Statistics 2010. The Medical Birth Registry of Norway 2012 [cited 2012 Mar 15]; http://mfr-nesstar.uib.no/mfr/. Accessed March 15, 2012.